Such scenarios might include pulmonary diseases, as GM-CSF is, for instance, highly expressed in bronchoalveolar lavage and sputum of patients with COPD compared to healthy controls (39, 40). The gene discussed is CSF2; the disease is chronic obstructive pulmonary disease.